Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents

NCT02726542 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Massachusetts General Hospital